Prev Close | 0.17 |
Day Low/High | 0.15 / 0.18 |
52 Wk Low/High | 0.13 / 1.92 |
Prev Close | 0.17 |
Day Low/High | 0.15 / 0.18 |
52 Wk Low/High | 0.13 / 1.92 |
Exchange | NASDAQ |
Shares Outstanding | 147.38B |
Market Cap | 24.98M |
P/E Ratio | N/A |
Div & Yield | N.A. (N.A) |
Indices keep hitting highs, yet volatility stays low.
But there are some speculative opportunities to be had.
The clinical-stage biopharmaceutical firm said Oct. 16 it has priced an underwritten public offering of five million shares at $16 apiece.
The Burlington, Mass.-based firm announced a proposed public offering of 4 million shares. It plans to use part of the net proceeds to fund manufacturing and commercialization of osteoarthritis knee pain treatment Zilretta.